First Saudi International Conference on Pharmaceutical Policy

Scientific Program
First Saudi International Conference on
Pharmaceutical Policy, Economics & Outcomes
KSAU-HS Convention Center
Day 1, 20 October 2014
Time
0700 - 0830
Topics
Speakers
Registration
0830 - 0900
Reference Pharmaceutical Pricing
0900 - 0920
Pharmaceutical Pricing in Saudi Arabia
0920 - 0950
0950 - 1000
1000 - 1040
1040 - 1100
1100 - 1120
1120 - 1140
1140 - 1200
1200 - 1220
1220 -1230
1340 - 1640
1500 – 1530
Prof. Sean Sullivan
Dean, College of Pharmacy, University of
Washington , USA
Dr. Fahad Al-Nutaify
SFDA
How Would Value Based Pricing Improve
Prof. Mike Drummond
Pharmaceutical Reimbursement Decision by Health
York University, UK
Care Institutions (Payers)
Panel Discussion
OPENING CEREMONY
Coffee Break
Prof. Mike Drummond
York University, UK
Prof. Sean Sullivan
Comparative Effectiveness Research
Dean, College of Pharmacy, University of
Washington, USA
Importance of National
Prof. Mike Drummond
Pharmacoeconomics/Submission Guidelines
York University, UK
Dr. Ivo Abraham
Pharmacoeconomics/Submissions Guidelines in
Professor, College of Pharmacy Arizona
Europe
University
Pharmacoeconomics/Submission Guidelines in
Dr. Dhafer Al-Shiban, Arizona University
Australia
Panel Discussion
Lunch/Prayer Break
Afternoon Workshops
Prof. Mike Drummond
York University, UK
Workshop on National Pharmacoeconomics /
Dr. Abdulaziz Al-Saggabi
Submission Guidelines Development
Director, Drug Policy & Economics Center,
Ministry of National Guard Health Affairs
Dr. Dough Burgoyne
Pharmacist Role in Establishing Disease
President, Academy of Managed Care
Management Programs
Pharmacy, USA
Dr. Pete Penna
Pharmacist Role in Medication Therapy
CEO, Formulary Resources
Management Services
Co-Founder & Past President of Academy
of Managed Care Pharmacy, USA
Prayer Time/Coffee Break
End Of Day 1
Introduction of HTA &Pharmacoeconomics
Evaluation
Scientific Program
First Saudi International Conference on
Pharmaceutical Policy, Economics & Outcomes
KSAU-HS Convention Center
Day 2, 21 October 2014
Time
0800 - 0830
0830 -0900
0900 - 0930
0930 - 0950
0950 - 1010
1010 - 10:20
1020 - 1030
1020 - 1050
1050-1120
1120-1130
1130-1140
1140-1200
1200-1220
1220-1230
1230 -1330
1330-1630
1500 – 1530
Topics
Speakers
Types of Local Outcomes Research Required to
Dr. Ivo Abraham
Support Pharmacoeconomics/HTA Studies in Saudi Professor, College of Pharmacy Arizona
Arabia
University
Need for Real World Data from National Databases Prof. Sean Sullivan
& Registries to Support HTA &Pharmacoeconomics Dean, College of Pharmacy, University of
Evaluation
Washington, USA
Outcomes Research in Saudi Arabia: Role in
Dr. Mohammad Al-Kelya,Head, Research
HTA/Pharmacoeconomics Evaluation
Quality Management, KAIMRC
Role of Pharmacoepidemiology in
Dr. Thamer Al-Shammari, Dean, College of
Pharmacoeconomics Evaluation
Pharmacy, University of Hail
Impact of Pharmacoeconomics& Outcomes
Prof. L Bootman, Dean, College of
Research on Quality of Patient Care
Pharmacy, University of Washington
Panel Discussion
Coffee Break
Performance (Outcomes) Based Risk Sharing
Agreement (PBRSAs) Between Pharmaceutical
Industry & Health Care Institutions (Payers)
Prof. Sean Sullivan
Dean, College of Pharmacy, University of
Washington, USA
Dr. Abdulaziz Al-Saggabi, Director, Drug
Policy & Economics Center, Ministry of
National Guard Health Affairs
Optimal implementation of Outcomes Based Risk
Sharing Agreements in Saudi Arabia
Panel Discussion
Coffee Break
Arizona University Experience in Building Capacity
Prof. L Bootman, Dean, College of
in Pharmaceutical Policy, Economics & Outcomes
Pharmacy, University of Washington
University of Washington Experience in Building
Prof. Sean Sullivan
Capacity in Pharmaceutical Policy & Outcomes
Dean, College of Pharmacy, University of
Research
Washington, USA
Panel Discussion
Lunch / Prayer Break
Afternoon Workshops
Prof. Mike Drummond
York University, UK
Conducting Optimal HTA
Dr. Abdulaziz Al-Saggabi
Director, Drug Policy & Economics Center,
MNGHA
Performance-Based (Outcomes Based) Risk Sharing Prof. Sean Sullivan
Agreements Between Pharmaceutical Industry and Dean, College of Pharmacy, University of
Health Care Institutions (Payers)
Washington , USA
Prayer Time/Coffee Break
End Of Day 2
Scientific Program
First Saudi International Conference
on Pharmaceutical Policy, Economics & Outcomes
KSAU-HS Convention Center
Day 3, 22 October 2014
Time
1200 - 1210
Speakers
Dr. Ali Al-Hammad
Pharmacoeconomics Evaluation: MNGHA
Pharmacoeconomics Specialist
Experiences
Drug Policy & Economics Center, MNGHA
Dr. Nada Abu-Shraie
Formularly Management
Clinical Pharmacist Specialist
Drug Policy & Economics Center, MNGHA
Evidence-Based Health Practice Principles: Role in
Dr. MazenFerwana
Drug Evaluation
Co-Director, National & Gulf Evidence Based
Center, MNGHA
Panel Discussion
Coffee Break
Dr. Doug Burgoyne
US Managed Care System
President, Academy of Managed Care
Pharmacy, USA
Dr. Pete Penna
CEO, Formulary Resources
Introduction of Pharmacy Benefit Management
Co-Founder & Past President of Academy of
Managed Care Pharmacy, USA
Dr. Doug Burgoyne
Management Programs Services Provided by
President, Academy of Managed Care
Pharmacy Benefit Management
Pharmacy, USA
Dr. Pete Penna
Medication Therapy Management Services Provided
CEO, Formulary Resources, Past President of
by Pharmacy Benefit Management
Academy of Managed Care Pharmacy, USA
Drug Utilization Evaluation Services by Pharmacy
Dr. Jeff Dunn, Vice President, VRX Pharmacy
Benefit Management
Services, LLC USA
Dr. Mark Singleton, Catamaran, USA
Role of IT in Pharmacy Benefit Management
Panel Discussion
12:10-12:40
CLOSING CEREMONY
12:40-13:40
Lunch/ Prayer Break
Afternoon Workshops
Drug Utilization Review by PBM to Improve Quality
Dr. Jeff Dunn, Vice President, VRX Pharmacy
of Care and Manage Escalating Pharmaceutical
Services, LLC USA
Expenditures
Dr. Mark Singleton, Catamaran, USA
Role of IT in Pharmacy Benefit Management
0830 - 0850
0850 -0910
0910 - 0930
0930 - 0940
0940 - 0950
0950 - 1010
1010- 1030
1030 - 1050
1050 - 1110
1110 -1140
1140 - 1200
1340 - 1640
Topics
Types of Local Outcomes Research Required to
Dr. Ivo Abraham
Support Pharmacoeconomics/HTA Studies in Saudi
Professor, College of Pharmacy
Arabia
Arizona University
End Of Day 3